Dignity Health

By Brian Dolan 04:08 am June 11, 2013
The California Health Care Foundation's CHCF Innovation Fund announced this week that it has invested a total of slightly more than $1 million in Madison, Wisconsin-based Asthmapolis, which offers a FDA-cleared inhaler sensor and app for people with asthma, COPD, or cystic fibrosis. CHCF has made two investments in Asthmapolis over the years but the bulk of the $1 million makes up its most recent...
By Brian Dolan 04:45 am March 12, 2013
A WellPoint health plan in Florida, called Amerigroup Florida, announced that it will offer Asthmapolis' FDA-cleared mobile health device and service to its members with asthma. Asthmapolis' device is a sensor that sits atop (most) inhalers used by patients who have asthma or COPD. The sensor transmits data to a companion app on the user’s mobile phone every time the inhaler is used. The app can...
By Brian Dolan 03:55 am February 21, 2013
Later today I'll be presenting alongside Rich Roth, the Vice President of Strategic Innovation at Dignity Health, which changed its name from Catholic Healthcare West last year. Dignity provides care to patients at 40 hospitals and care centers across California, Nevada, and Arizona. It has also been one of the more pioneering healthcare systems when it comes to mobile health adoption. Rich and I...
By Brian Dolan 05:24 am July 11, 2012
Asthmapolis announced today that the US Food and Drug Administration (FDA) has granted its asthma sensor and companion software 510(k) clearance. The company's device is a sensor that sits atop (most) inhalers used by patients who have asthma or COPD. The sensor transmits data to a companion app on the user's mobile phone every time the inhaler is used. The app can then track the time and...
By Brian Dolan 08:48 am February 20, 2012
Asthmapolis is working with Dignity Health, formerly Catholic Healthcare West, to equip its Sacramento-based asthma patients with GPS-enabled inhalers that send real-time breathing data to physicians' smartphones. Asthmapolis is ramping up production of its device, a sensor that sits atop most inhalers, at a Wisconsin-based device manufacturing plant. The device was expected to launch last year....